HFA Premium Access

Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus

Congress Presentation

About the speaker

Doctor Hanna Froehlich

University hospital Heidelberg, Heidelberg (Germany)
0 follower

35 more presentations in this session

Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: A post-hoc analysis from the REWIND randomized trial

Speaker: Professor K. Branch (Seattle, US)

Thumbnail

Prognostic value of pulse pressure in heart failure with preserved ejection fraction: findings from the RICA registry

Speaker: Doctor I. Bravo Candela (Sevilla, ES)

Thumbnail

Repetitive ambulatory doses of levosimendan for patients as bridge to heart transplant. Findings from the LEVO-T registry.

Speaker: Doctor J. De Juan Baguda (Madrid, ES)

Thumbnail

Sacubitril/valsartan use patterns among older adults with heart failure in routine care: a US population-based cohort study of >25,000 medicare beneficiaries

Speaker: Doctor A. Bhatt (Boston, US)

Thumbnail

Efficacy of sodium glucose cotransporter-2 inhibitors for heart failure with preserved and with mildly reduced ejection fraction: a systematic review and meta-analysis

Speaker: Doctor R. Cordovez (Cebu City, PH)

Thumbnail

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 3

Speakers: Doctor H. Froehlich, Professor K. Branch, Doctor I. Bravo Candela, Doctor J. De Juan Baguda, Doctor A. Bhatt...
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb